Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 10,857 shares at $14.00 ($152K) on 2018-06-28, disclosed to the SEC on 2018-07-02.
Open-market sale of $152k CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 10,757 | $151K | 99.1% |
| 2 | $14.10 | 100 | $1K | 0.9% |
| Total | $14.00 avg | 10,857 | $152K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |